Antihistamines are not inherently bad for you, but the type you take and how long you take it matter significantly. Short-term use of newer antihistamines carries minimal risk for most adults. Older antihistamines, however, come with a well-documented set of side effects, and long-term use of those older drugs has been linked to a meaningful increase in dementia risk. The distinction between these two classes is the most important thing to understand.
First-Generation vs. Second-Generation: A Major Gap
Antihistamines fall into two broad categories, and they are not equally safe. First-generation antihistamines, like diphenhydramine (Benadryl), were developed decades ago. They cross easily into the brain, which is why they cause drowsiness, foggy thinking, dry mouth, and blurred vision. They also wear off quickly, requiring doses every four to six hours.
Second-generation antihistamines, including loratadine (Claritin), fexofenadine (Allegra), and cetirizine (Zyrtec), were designed to work without flooding the brain. They have high selectivity for histamine receptors outside the central nervous system and much lower brain permeability. They last longer, typically covering a full 24 hours per dose, and produce far fewer unwanted effects. The FDA classifies fexofenadine and loratadine as nonsedating. Cetirizine is technically classified as sedating, though most people tolerate it well.
Major allergy treatment guidelines now strongly recommend second-generation antihistamines over first-generation drugs as first-line treatment. The older drugs, according to published evidence reviews, “are no longer recommended for patient use because of their well-documented negative adverse effect profile.”
The Dementia Concern Is Real but Specific
The most alarming risk tied to antihistamines involves long-term use of first-generation drugs. These older antihistamines are anticholinergic, meaning they block a chemical messenger called acetylcholine that plays a central role in learning and memory.
A University of Washington study tracked nearly 3,500 adults aged 65 and older for an average of seven years. During that period, 800 participants developed dementia. Those who had taken anticholinergic drugs (including first-generation antihistamines) for the equivalent of three years or more had a 54% higher dementia risk compared to those who used the same drugs for three months or less. That’s a substantial increase, and it was dose-dependent: more cumulative use meant higher risk.
This finding applies specifically to anticholinergic drugs. Second-generation antihistamines do not have strong anticholinergic activity, so they are not implicated in the same way. If you’ve been reaching for diphenhydramine nightly as a sleep aid for months or years, this is worth paying attention to. Occasional use for a bad allergy day is a different situation entirely.
Effects on Sleep Quality
Many people take first-generation antihistamines specifically to help them fall asleep. While diphenhydramine does cause drowsiness, sleep researchers have raised concerns about the quality of sleep it produces. The sedation from anticholinergic drugs tends to suppress certain sleep stages, meaning you may fall asleep faster but wake up feeling groggy or unrested. Tolerance also builds quickly, sometimes within just a few days, pushing people to take higher doses for the same effect.
Second-generation antihistamines generally do not cause significant sleepiness, with the partial exception of cetirizine. None of them are intended or recommended as sleep aids.
Who Should Be Cautious
Certain groups face higher risks from antihistamines, particularly the first-generation type.
- People with narrow-angle glaucoma: Both first- and second-generation antihistamines can narrow the drainage passage in the eye, potentially triggering an acute glaucoma attack. The American Academy of Ophthalmology lists diphenhydramine, loratadine, fexofenadine, and cetirizine as risky for patients with narrow angles. If you’ve had corrective treatment like laser iridotomy or cataract surgery to open the angle, this risk goes away.
- People with liver or kidney problems: Most antihistamines are processed by the liver, and some (like cetirizine) rely partly on the kidneys. If either organ isn’t functioning well, the drug can build up in your system. Dose reductions are typically recommended rather than complete avoidance, but your prescriber needs to know about any impairment.
- Children: Not all children’s antihistamines are approved for every age. Some are cleared for children as young as six months, but others are not. Children are more sensitive to these drugs than adults and can experience excitability or excessive drowsiness at doses that would be harmless for a grown person. The FDA warns parents to always check the label for age-specific guidance and to watch for duplicate active ingredients if a child is taking more than one medication.
- Pregnant women: Loratadine and cetirizine are the antihistamines most commonly considered acceptable during pregnancy for mild allergy symptoms, according to the Mayo Clinic. Even so, the decision involves weighing benefits against risks with a healthcare provider.
Daily Long-Term Use
For people with year-round allergies, taking a second-generation antihistamine daily is common practice and generally considered safe. These drugs have been studied in long-term use and don’t show the same accumulating risks as their older counterparts. They don’t build tolerance the way first-generation drugs do, so you won’t need increasing doses over time.
That said, “safe for daily use” doesn’t mean “zero effects on your body.” Antihistamines block histamine, which plays roles beyond allergies. Histamine is involved in regulating stomach acid, wakefulness, and even skin barrier repair. Second-generation drugs are more targeted than first-generation ones, but no drug acts with perfect precision. If you’re taking an antihistamine daily for months, it’s worth periodically reassessing whether you still need it rather than continuing on autopilot.
The Bottom Line on Safety
If you take a second-generation antihistamine like loratadine or fexofenadine for seasonal or chronic allergies, the evidence suggests this is low-risk for most people. The real concerns center on first-generation drugs: the sedation, the anticholinergic burden, and the association with cognitive decline when used heavily over years. Occasional use of diphenhydramine for a bad allergy flare is unlikely to cause lasting harm. Using it nightly as a sleep aid for months is a different calculation, especially if you’re over 65. Switching to a newer antihistamine, when possible, eliminates most of the risks that bring people to search this question in the first place.